Dreicer R - Search Results

1

Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer.

Dreicer R, MacLean D, Suri A, Stadler WM, Shevrin D, Hart L, MacVicar GR, Hamid O, Hainsworth J, Gross ME, Shi Y, Webb IJ, Agus DB. Dreicer R, et al. Clin Cancer Res. 2014 Mar 1;20(5):1335-44. doi: 10.1158/1078-0432.CCR-13-2436. Epub 2014 Jan 13. Clin Cancer Res. 2014. PMID: 24418642 Clinical Trial.

2

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.

Clark PE, Peereboom DM, Dreicer R, Levin HS, Clark SB, Klein EA. Clark PE, et al. Among authors: dreicer r. Urology. 2001 Feb;57(2):281-5. doi: 10.1016/s0090-4295(00)00914-6. Urology. 2001. PMID: 11182337 Clinical Trial.

3

Phase II trial of GM-CSF in advanced prostate cancer.

Dreicer R, See WA, Klein EA. Dreicer R, et al. Invest New Drugs. 2001;19(3):261-5. doi: 10.1023/a:1010637105066. Invest New Drugs. 2001. PMID: 11561685 Clinical Trial.

4

Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.

Hutson TE, Molto L, Mekhail T, Elson P, Finke J, Tannenbaum C, Borden E, Dreicer R, Olencki T, Bukowski RM. Hutson TE, et al. Among authors: dreicer r. Clin Cancer Res. 2003 Apr;9(4):1354-60. Clin Cancer Res. 2003. PMID: 12684404 Clinical Trial.

5

Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer.

Dreicer R, Magi-Galluzzi C, Zhou M, Rothaermel J, Reuther A, Ulchaker J, Zippe C, Fergany A, Klein EA. Dreicer R, et al. Urology. 2004 Jun;63(6):1138-42. doi: 10.1016/j.urology.2004.01.040. Urology. 2004. PMID: 15183967 Clinical Trial.

6

Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer.

Dreicer R, Klein EA, Elson P, Peereboom D, Byzova T, Plow EF. Dreicer R, et al. Urol Oncol. 2005 Mar-Apr;23(2):82-6. doi: 10.1016/j.urolonc.2004.08.013. Urol Oncol. 2005. PMID: 15869991 Clinical Trial.

7

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: dreicer r. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

8

Phase I/II study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer.

Dreicer R, Petrylak D, Agus D, Webb I, Roth B. Dreicer R, et al. Clin Cancer Res. 2007 Feb 15;13(4):1208-15. doi: 10.1158/1078-0432.CCR-06-2046. Clin Cancer Res. 2007. PMID: 17317831 Clinical Trial.

9

Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.

Magi-Galluzzi C, Zhou M, Reuther AM, Dreicer R, Klein EA. Magi-Galluzzi C, et al. Among authors: dreicer r. Cancer. 2007 Sep 15;110(6):1248-54. doi: 10.1002/cncr.22897. Cancer. 2007. PMID: 17674353 Free article. Clinical Trial.

10

Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.

Bradley DA, Dunn R, Nanus D, Stadler W, Dreicer R, Rosenberg J, Smith DC, Hussain M. Bradley DA, et al. Among authors: dreicer r. Clin Genitourin Cancer. 2007 Dec;5(7):460-3. doi: 10.3816/CGC.2007.n.037. Clin Genitourin Cancer. 2007. PMID: 18272031 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters